verified SJR 12,19 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Elsevier Ltd

workspace_premium Q1 — Endocrinology lock Subscription

The Lancet Diabetes and Endocrinology

The Lancet Diabetes and Endocrinology is a journal indexed in SJR in Endocrinology and Endocrinology, Diabetes and Metabolism with an H index of 189. It has an SJR impact factor of 12,19 and it has a best quartile of Q1. It has an SJR impact factor of 12,19.

The Lancet Diabetes and Endocrinology focuses its scope in these topics and keywords: diabetes, type, patients, change, disease, againeffects, differencepcsk, activity, advances, diabetic, ...

ISSN: 2213-8587

Publisher: Elsevier Ltd

Category: Endocrinology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

12,19 Q1

H-index 189

Acceptance rate pie_chart

22% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

12,19

H-index

189

Docs (year)

193

Docs 3y

553

Total refs

4445

Cites 3y

6796

Citable 3y

198

Cites/Doc 2y

10.82

Ref/Doc

23.03

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes

Weight loss: slow and steady does not win the race

Effectiveness of an mHealth intervention to improve the cardiometabolic profile of people with prehypertension in low-resource urban settings in Latin America: a randomised controlled trial

Effect of cancer treatment on hypothalamic-pituitary function

Dying for a good night's sleep

Does mortality risk vary among sulfonylureas?

Distal technologies and type 1 diabetes management

Diabetic kidneys do deserve a lifestyle change

Diabetic foot disease: moving from roadmap to journey

Diabetes prevention and continuing health-care reform in China

Country in Focus: turning the tide of diabetes in Fiji

Country in Focus: economic transition and non-communicable diseases in Thailand

SHOW MORE ARTICLES

Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial

A story of a golden boy

Cardiovascular safety of albiglutide and other glucagon-like peptide-1 receptor agonists

Cardiovascular health promotion in adolescents: a vital investment

Can we safely state that bariatric surgery helps prevent type 2 diabetes?

Bone health in survivors of childhood cancer

Body language

Association between 25-hydroxyvitamin D and type 2 diabetes

Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial

An artistic awakening

ALTITUDE: defining a ceiling for blockade of the renin-angiotensin system?

Abdominal lipohypertrophy without insulin injection

FAQs

The Lancet Diabetes and Endocrinology has an SJR of 12,19 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for The Lancet Diabetes and Endocrinology is 22%.

The Lancet Diabetes and Endocrinology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of The Lancet Diabetes and Endocrinology?

What is the APC / publication cost?

What is the acceptance rate?